HRT Side Effects: What's Normal, What Needs a Doctor, and What It Does for Your Hair and Skin

What are the most common HRT side effects?

Ask what hormone therapy actually feels like in the first few weeks, and the honest answer is: a little unpredictable. Your body is adjusting to a hormone level it hasn't seen in months or years, and that adjustment shows up as a fairly consistent, well-documented cluster of effects rather than anything mysterious.

• Breast tenderness or swelling — often the first thing women notice, and the most common early complaint
• Bloating and fluid retention, sometimes described as feeling puffy or a few pounds heavier
• Breakthrough bleeding or spotting, especially in the first months or right after a dose change
• Headaches, including migraines in women who are prone to them
• Nausea, dizziness, or mild fatigue, particularly with oral estrogen
• Mood swings or irritability, which track more closely with progestin type than with estrogen dose

The American College of Obstetricians and Gynecologists puts it plainly: most women tolerate hormone therapy well, but typical doses are still associated with adverse effects including breast tenderness, vaginal bleeding, bloating, and headaches. None of that is a sign you're doing something wrong — it's closer to what you'd expect from any new, deliberate hormone exposure.

Is HRT safe, given this list?

For most women, yes — the common side effects above and the serious risks below sit on entirely different scales. The North American Menopause Society's 2022 position statement frames the serious risks as rare, generally under ten additional cases per ten thousand women per year, clustered around three things: blood clots, stroke, and, specifically with combined estrogen-progestin regimens, breast cancer.

In real numbers: estrogen-only therapy is linked to roughly eleven additional cases of venous thromboembolism per ten thousand woman-years. Combined estrogen-progestin therapy runs higher, at about twenty-one. Stroke risk in women under 60 works out to about one additional stroke for every thousand women who use hormone therapy for five years. Breast cancer risk with combined therapy runs under one additional case per thousand woman-years — small enough that NAMS and ACOG both weigh it against the benefit most women get for hot flashes, sleep, and bone protection.

Timing matters more than most marketing language admits: starting hormone therapy within about ten years of your last period, and before age 60, is consistently associated with the most favorable risk profile in the research these societies reviewed.

Which side effects are serious enough to call a doctor about?

A short, specific list sits apart from the ordinary adjustment symptoms above, and it's worth memorizing rather than looking up under pressure.

• Leg swelling, pain, warmth, or redness in one leg — a possible sign of a blood clot (deep vein thrombosis)
• Sudden chest pain or shortness of breath
• A sudden, severe headache unlike your usual pattern
• New vision changes — blurred vision, double vision, or vision loss
• Sudden difficulty speaking, confusion, or weakness on one side of the body

Any one of those calls for same-day medical attention, not a message to your care team that can wait until morning. Mayo Clinic and ACOG both flag this exact cluster because it overlaps with the rare but real clot and stroke risk described above — catching it early is part of why the absolute risk numbers stay as low as they do.

Does HRT cause hair loss — or does it help with hair loss?

This is the question that trips women up most, because the timing is genuinely confusing. Perimenopause itself often causes hair thinning as estrogen declines, so if you start HRT during that same window, it's hard to tell whether shedding you notice a few weeks in is the hormone therapy, the perimenopause it's treating, or plain coincidence.

The more common pattern by far is the opposite one: restoring estrogen tends to help keep hair follicles in their growth phase rather than pushing them into shedding. That said, a minority of women do see increased shedding on certain regimens — most often tied to androgenic progestins, or to added testosterone at doses that push levels above the normal female range. If shedding starts after a formulation change specifically, the progestin or testosterone component is a more likely driver than the estrogen itself. For the fuller mechanism, and what else could be going on, see perimenopause hair loss.

Can HRT actually help with hair thinning?

For many women, yes — though it's worth being precise about what that means. Estrogen extends the growth (anagen) phase of the hair cycle and can reduce the diffuse shedding that shows up when estrogen drops sharply. Women who start HRT specifically because their hair loss tracks the hormonal transition often see improvement in density and shedding over time.

What HRT is not is an FDA-approved hair-loss treatment, and it won't touch hair loss that's genuinely androgenetic — the gradual, pattern thinning at the crown and part line — the way a dedicated treatment for that specific type would. If your thinning is diffuse and recent, hormone therapy is a reasonable piece of the picture. If it's a widening part that's been progressing for years, that's a separate conversation with a dermatologist.

What does HRT do for your skin?

Skin takes a real, measurable hit after menopause — collagen can drop by as much as 30% in the first five years. Skin elasticity follows a similar path, measured declining by roughly 1.5% a year in early postmenopausal women. That's not a subjective complaint; it's what dermatology research on estrogen and skin structure consistently finds.

Estrogen therapy partially reverses that. Several studies, including systematic reviews of hormone therapy and skin outcomes, show measurable increases in collagen content, dermal thickness, elasticity, and hydration among women using estrogen therapy — most consistently in those who start it near the onset of menopause rather than years later. The effect isn't uniform (a few trials found improved collagen without a matching change in elastic fibers), and HRT isn't prescribed as a skin treatment on its own. If you're searching for the single best HRT for skin and hair, the honest answer is that delivery route matters less for this particular outcome than simply restoring estrogen consistently and starting reasonably close to menopause.

How long do HRT side effects last before they settle?

Most of the early side effects follow a fairly predictable arc. Breast tenderness typically peaks in the first few weeks and eases over the following three months, though it lingers longer for some women. Bloating tends to improve within two to three months. Breakthrough bleeding is most common in the first six months — particularly on continuous combined regimens — and usually tapers as your body settles into a steady hormone level instead of perimenopause's sharper swings.

If a side effect hasn't budged by three to six months, that's the point to loop back to your prescriber about a dose or formulation change rather than waiting it out indefinitely.

How to manage the common side effects

A few practical adjustments cover most of what shows up in the first few months, without requiring you to just push through it.

• Breast tenderness: often eases with a lower estrogen dose or a switch from oral to transdermal delivery — raise it at your next follow-up rather than pushing through it
• Bloating: taking oral estrogen with food, and giving it a full cycle or two before judging whether it's settling, resolves most cases
• Spotting: track the pattern — timing, how much, how long — so your prescriber can tell ordinary breakthrough bleeding from something that needs a closer look
• Nausea: usually a first-pass-effect issue with oral estrogen — switching to a patch, gel, or cream often resolves it because it bypasses the liver
• Mood changes: track more closely with progestin type than estrogen dose — micronized (bioidentical) progesterone is associated with fewer mood-related complaints and better sleep than some synthetic progestins in the research comparing them

Does the type of HRT change your side-effect risk?

Yes, in two specific ways worth understanding before you pick a formulation. First, route: oral estrogen passes through the liver before it reaches the bloodstream (the "first-pass effect"), which raises clotting factors more than transdermal delivery does. Pooled research comparing the two found a meaningfully elevated clot risk with oral estrogen and close to no added risk with patches, gels, or creams — which is why NAMS and ACOG both note transdermal routes as the lower-VTE-risk option, particularly for women who already carry some clotting risk.

Second, progestin type. Micronized (bioidentical) progesterone appears to carry a different, generally milder side-effect profile than older synthetic progestins — less mood disruption, better sleep, and, in some of the research comparing the two, no added clot risk of its own. If mood or sleep was the side effect that worried you most, this is the ingredient to ask about specifically, not just the estrogen dose.

Compounded versus FDA-approved is a separate axis from either of those. A compounded patch, cream, or capsule can be chemically identical to a manufactured one, but the finished compounded product hasn't gone through the FDA's own premarket review the way a manufactured drug has — a regulatory distinction, not automatically a safety verdict, but one worth knowing before assuming "bioidentical" and "FDA-approved" mean the same thing.

Where to start if you want help managing a side effect, not just a prescription

If you're choosing a provider with an eye toward what happens after day one — not just the starting price — the real differences between platforms show up in labs, follow-up cost, and how easy it is to change formulation.

Alloy builds side-effect management into its base price: physicians are all Menopause Society-certified, and every follow-up thread is included at no extra charge, so a formulation change after breakthrough bleeding or persistent headaches doesn't mean a second bill.

Midi Health leans on labs rather than trial and error — its standard care model includes bloodwork, so a side effect that isn't settling gets measured rather than guessed at. That's most useful for women with PPO insurance, since follow-ups bill like any other specialist visit rather than a separate cash charge.

Winona is the cheapest way to experiment: there's no consult fee attached to switching from a patch to a tablet or cream if one formulation isn't agreeing with you, though you're doing that without lab confirmation either way. See the full HRT cost breakdown for how Winona's à la carte pricing compares to the other providers.

Wisp's flat $99 fee bundles the consult with three months of care-team access, which covers an early adjustment without a second charge — confirm what happens to that access after the three-month window before you commit. Evernow folds ongoing physician access and its standard labs into a membership fee, so monitoring is part of the plan rather than something you request separately — the trade-off is that the membership continues whether or not you use it that month.